Design, synthesis and potent cytotoxic activity of novel podophyllotoxin derivatives

Wen-Qun Li1, Xu-Li Wang1, Keduo Qian2

  • 1School of Pharmacy, Lanzhou University, Lanzhou 730000, PR China.

Insights

New podophyllotoxin derivatives show potent anticancer activity, outperforming etoposide against resistant tumor cells. Compounds 13b and 13o are promising candidates for next-generation epipodophyllotoxin antitumor therapies.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Oncology

Background:

  • Podophyllotoxin and its derivatives are established anticancer agents.
  • Drug resistance remains a significant challenge in cancer chemotherapy.
  • Developing novel cytotoxic compounds is crucial for overcoming resistance.

Purpose of the Study:

  • To synthesize and evaluate novel acyl thiourea derivatives of podophyllotoxin and 4'-demethylepipodophyllotoxin.
  • To assess the cytotoxicity of these new compounds against human tumor cell lines.
  • To identify potent candidates for new antitumor therapies, particularly against drug-resistant cancers.

Main Methods:

  • Synthesis of twenty new acyl thiourea derivatives.
  • Cytotoxicity screening against A-549, DU-145, KB, and KBvin human tumor cell lines.
  • Determination of IC50 values and establishment of structure-activity relationships (SAR).

Main Results:

  • Compounds 13b, 13c, and 13o demonstrated superior cytotoxic activity compared to etoposide (IC50: 0.098–1.13 μM).
  • Compounds 13b and 13o showed significant efficacy against the drug-resistant KBvin cell line (IC50: 0.098 μM and 0.13 μM, respectively).
  • Etoposide exhibited no activity against the KBvin cell line.

Conclusions:

  • Acyl thiourea derivatives of podophyllotoxin exhibit potent anticancer properties.
  • Compounds 13b and 13o are highly effective against drug-resistant cancer cells.
  • These compounds represent promising leads for the development of novel epipodophyllotoxin-based antitumor agents.

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...